About EPIC

Study Design

Background

The European Prospective Investigation into Cancer and Nutrition (EPIC) is a prospective cohort with more than 521 000 study participants enrolled from 23 centres in 10 western European countries. Detailed information on diet, lifestyle characteristics, anthropometric measurements, and medical history was collected at recruitment (1992—1999).

Biological samples including plasma, serum, leukocytes, and erythrocytes were also collected at baseline from 387 889 individuals and are stored at the International Agency for Research on Cancer – World Health Organization (IARC-WHO) and mirrored at EPIC collaborating centres. Overall, the EPIC biorepositories host more than 9 million aliquots, constituting one of the largest biobanks in the world for biochemical and genetic investigations on cancer and other chronic diseases. Follow-up measures of lifestyle exposures have been collected and will be centralized at IARC in 2014.